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Murine monoclonal antibodies to human anchoring 
fibrils reacted with human and monkey cervix, tongue, 
esophagus, and vagina. Rat, mouse, and guinea pig tis-
sues were negative. In 11 patients with dystrophic re-
cessive epidermolysis bullosa there was no reaction by 
immunofluorescence and immunoelectron microscopy. 
Other forms of epidermolysis bullosa had normal reac-
tivity. 
Recessive dystrophic epidermolysis bullosa (RDEB) varies 
in its severity from a mild, localized disorder to a generalized 
disease with muti-lating sequelae [1,2] . The severe, generalized 
(gravis) type has a marked decrease or absence of anchoring 
fibrils (AF) (2], and increased collagenase activity [3]. The 
dominantly inheri ted forms of EB dystrophica have morpho-
logically abnormal AF which may be decreased in number [4] . 
AF are ascribed a role in stabilizing the attachment of the 
dermis and epi t helium in skin, cervix, buccal and lingual mu-
cosa, esophagus, and cornea [5].· AF have a characteristic ultra-
structu ral appearance with a central transverse-banded portion 
and fan-shaped ends extending toward the epidermis and der-
mis. They form a network below the lamina densa: one end 
inserts directly into the lamina densa (basal lamina) , the other 
end extends in to t he dermis or may connect with adjoining AF 
[2]. Their biochemical composition is unknown; a relation to 
collagen is suggested by t heir sensitivity to bacterial collagenase 
[6], but they do not react with antibodies to any known collagen 
type. 
Attempts to isolate and characterize the AF have been un-
successful [7]. Using monoclonal techniques [8], we produced 
antibodies to t he AF and have applied those antibodies to study 
EB. 
MATERIALS AND METHODS 
Immunization and Cell Culture 
ME-180 cells, a human ce rvical carcinoma cell line, and the 8 M 
urea-dithreitol extract of human stratum corneum [9) were used as 
antigens for immunization. Murine monoclonal antibodies were pro-
duced using NS1/1-Ag- 1 myeloma cells employing standard methods 
[6]. 
Antibody Testing and Characterization 
Antibodies initially were determined by radioimmunoassay using 
intact ME-180 cells as an antigen [10). AF1 defines an antibody derived 
from the ME-180 immunization; AF2, an antibody from the stratum 
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corneum immunization. (AF1 has been called DUX 5.2 previously 
[10) .) 
Immunoglobulin type was determined by Ouchterlony double-diffu-
sion using immunoglobulin class-specific antisera (Miles Laboratories, 
Inc., Naperville, Illinois) and chromatographic behavior of the immu-
noglobulin on a staphylococcal protein A column (Sigma, St. Louis, 
Missouri) [11) . 
Immunofluorescence and Immunoglobulin Microscopy 
Immunofluorescence was performed by standard techniques [10) 
using as a second antibody 1:10 to 1:100 fluoresceinated rabbit anti-
mouse lgG (Cappel Laboratories, Cochranville·, Pennsylvania). Con-
t rols for immunof1uorescent studies included concentrated myeloma 
supernatant and pure mouse lgG~. isolated from mouse serum using a 
staphylococcal A column [11). 
lmmunoelectron microscopy was performed on O.C.T. (Miles Lab-
oratories, Inc.) embedded t issues as previously detailed [10] . 
RESULTS 
Two murine monoclonal antibodies (AFl and AF2) , both 
IgG~, kappa light chain, reacted with the human skin basement 
membrane zone and those human tissues known to contain AF 
(skin, cervix, esophagus, tongue, vagina, and buccal mucosa) , 
but not with thyroid, kidney, lung, trachea, rectum, stomach, 
or ileum (Fig lA ). AFl reacted with green macaque monkey 
skin , pa lm or chest, but not rat, mouse, guinea pig, or rabbit 
skin. Immunoelectron microscopy demonstrated localization of 
AFl and AF2 to the area immediately subjacent to the lamina 
densa, although a somewhat different distribution of immuno-
reaction product was evident with the two antibodies. These 
patterns appeared to be independent of antibody concentration. 
AFl was distributed in the lower (dermal) portion of the lamina 
densa, in the area immediately below the lamina d·ensa, and on 
or near AF. The reaction product associated with AFl tended 
to become confluent even with serial di lution . The immuno-
reactant produced by AF2 was more discrete and located in the 
area below the lamina densa associated with AF (Fig 2). To a 
lesser extent, the reaction product was present in the lamina 
densa. Rabbit antihuman fibronectin and the sera of a p,atient 
with acquired EB [12] did not interfere with AFl binding to 
normal human skin. 
Localization of Antibodies in Epidermolysis Bullosa 
Patients with various forms of inherited EB were studied to 
define further the antigenic specificity of the AFl and AF2 
(Table I), using immunofluorescent techniques. No reaction 
with either antibody was seen at the basement membrane zone 
of normal-appearing, unblistered skin or experimentally blis-
tered skin of 11 patients with RDEB (Fig lB). The never-
blistered skin of a 33-h-old infant with RDEB did not react 
with AFl or AF2. The unblistered skin of patients with junc-
tional EB (5 patients), EB simplex (4 patients) , and EB dys-
trophica dominant (Pas ini type) (3 patients), all ultrastruc-
turally confirmed, demonstrated basement membrane zone 
staining with both AFl and AF2. In experimentally blistered 
skin of patients with junctional EB and EB simplex, both 
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FIG 1. A, Normal human skin. The reaction of normal human skin 
wit h murine monoclona l a nt ibody AFL Staining was done as described 
in Material:; and M ethods with t he addition of a methyl green counter-
stain wh ich stains t he nucleus. A t hick subepiderma l band of staining 
cha racterizes AF1 (original mag X 200). B, Nonblistered human skin 
from a patient wi t h recessive dystrophic epidermolysis bullosa, stained 
wi t h AFl as described in Materials and Methods. No methyl green 
coun te rstain. No basement membrane zone staining (original mag X 
200) . 
antibodies reacted posit ively and were locali zed to the dermal 
side of t he induced epidermal-dermal separation. It was not 
possible to produce blisters experimentally in the dominant 
dystrophic pat ients. 
lmmunoelectron microscopy confirmed these observations. 
In RDEB no immunoreaction product was present below the 
lamina densa wi th either AFl or AF2 (Fig 3). A paucity or 
absence of AF below the lamina densa was evident; whereas, in 
junctional EB, localization of AFl and AF2 was seen (Fig 4) in 
the sub-basal lamina area in a distribution pattern similar to 
that seen in normal human skin controls (Fig 2). 
DISCUSSION 
The monoclonal antibodies, AFl and AF2, reacted wit h var-
ious t issues, including skin and esophagus, known to possess 
AF. The unblistered and experimentally blistered skin of pa-
tients with RDEB failed to react with both ant ibodies; whereas 
the skin of patients with junctional EB and EB simplex, which 
have a normal component of AF, did react. In severe generalized 
(gravis) RDEB epidermal-dermal separation occurred in the 
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F IG 2. Normal human skin . lmmunoelectron micrograph, using mu-
rine monoclonal a nt ibody with junctional spec ificity, AF2, shows re-
action product below t he lamina densa (LD) in association with an-
choring !ibri ls (arrows). Uranyl acetate and lead citrate stain . Calibra-
tion bar = 1 11m . 
TABLE I. Reactivity of junctional reacting monoclonal antibodies AFJ 
and A F2 in uariou.s forms of epidermolysis bullosa by 
immunofluorescence 
Disease (No. of patients) 
RDEB severe ge neralized 
gravis type ( ll) 
Junct ional EB (5) 
EB simplex (4) 
EB dystroph ica dominant 
albopapuloid (Pasini ) 
type (3) 
Unblislered skin 







Expe rimenl a lly 
blis te red skin 
AFl and AF2 
+ Dermal side of 
separation 
+ Dermal side of 
separation 
* 
BMZ = basement membrane zone; EB = epidermolysis bullosa; - = 
no reaction. 
* Blisters could not be induced exper imentally. 
FIG 3. RDEB (severe generalized or gravis type). Unblistered skin. 
Jmmunoelectron micrograph using AF2 shows no reaction product 
below the lamina densa (LD). Note absence of AF below the lamina 
densa . Uranyl acetate and lead cit rate sta in . Calibration bar= 1 11m . 
area below t he lamina densa. AF are sparse or absent, even in 
t he normal-appearing, unblistered skin of this disease [1 ,2). On 
the other hand , junctional EB produces separation in the 
lamina rara and EB simplex cleaves within t he cytoplasm of 
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FIG 4. Junctional EB. Unblistered skin. lmmunoelectron micro-
graph using AF2 shows reaction product below lam ina densa (LD) in 
association with AF (thick arrow). Note small , densely stained, abnor-
mal hemidesmosomes (thin arrow) which characterize junctional EB. 
Uranyl acetate and lead citrate stain. Calibration bar= 1 !Jill. 
t he epidermal basal cells [1]. In both of the latter diseases, AF 
are qualitatively and quantitatively normal. 
Taken together with the immunoultrastructural localization 
of these antibodies in association with AF at the ep idermal-
dermal junction of sk in , the findings indicate that the antigenic 
specificity of AF1 and AF2 is directed to AF, a portion of these 
structures, or a very closely associated antigenic molecule. In 
the Pasini form of EB, the reaction of AF1 and AF2 could not 
be distinguished from normal. Dominant dystrophic EB of t he 
albopapuloid (Pasini) type presents morphologically abnormal 
AF in both normal-appearing and blister-prone sk in areas 
which may or may not be decreased in number [4 ,5 ]. The 
component of the AF which may be altered in the Pasini disease 
is not altered antigenically as detected by AF1 and AF2. 
We cannot determine with certainty at this time whether 
AF1 and AF2 have identical antigenic specificities, a lthough 
they produce simi lar reactivity in EB skin and other tissues 
and simi lar localization below the lamina densa. However, the 
two antibodies have demonstrated consistently a somewhat 
different distribution pattern of immunoreaction product. This 
may indicate antigenic spec ificity to different portions of AF 
or associated antigens. Of the two antibodies, AF2 seems most 
definitely localized to AF on immunoelectron microscopy (Fig 
2). The large size of the reaction product produced by peroxi-
dase labeling, in comparison with the AF themselves, makes 
precise localization on the fibril somewhat uncertain. 
On a practical note, both antibodies faithfully detect reces-
sive EB with decreased or absent AF. Both the unblistered and 
blistered skin of RDEB were unreactive with AF1 and AF2. 
Vol. 81, No.5 
These antibodies could prove useful as an aid of diagnosis in 
EB, especially in situations where electron microscopy is not 
readily available (Fig 1A,B). Hintner et al have used pemphi-
goid antibodies and antibodies to type IV collagen and lamin in 
to document the level of separation in the skin in various forms 
of EB [13]. Breathnach et al [14] have described a monoclonal 
antibody (KF-1) that reacts with a component of the lamina 
densa which is absent in dystrophic epidermolysis bullosa. The 
relationship of the component(s) identified by KF-1 and AF1 
and AF2 remains to be determined. 
AF1 and AF2 would be useful additions to such a panel of 
antibodies in the determination of specific types of EB. In 
addition , the antibodies may present a new tool for the objective 
evaluation of the response to treatment, and the antibodies can 
be used in the isolation and characterization of the AF. 
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